Biotech and Pharmaceutical
News & Jobs
Last Price
0.15 (11.13.09 6:40 PM EST)
Change (%)
- (-)
Volume
-
Open
-
Previous Close
0.15
Day High
0.15
Day Low
0.15
Bid
0.14 x 100
Ask
0.16 x 200
Average Volume
28,574
Shares Outstanding
12.44M
Market Cap
1.9M
Year High
2.98
Year Low
0.08
Earnings Per Share
-0.48
P/E Ratio
-
Dividend
N/A
Yield
N/A
Symbol
Last
Change (%)
ISD
0.33
+0.03 (+8.20%)
BRST
0.10
+0.00 (+1.94%)
COCCF
0.30
+0.00 (+0.00)
SAR
0.15
+0.04 (+36.36%)
XRM
0.75
+0.00 (+0.00)
BSGC
0.03
+0.00 (+0.00)
0.04
+0.00 (+0.00)
Fri, Nov 06, 2009
Aspyra to Demonstrate Latest Release of AccessNET PACS with Mammography Viewing (510(k) Pending) at RSNA 2009
-
Business Wire
Tue, Oct 27, 2009
Aspyra Announces Voluntary Delisting of Its Common Stock from NYSE Amex
-
Business Wire
Wed, Oct 14, 2009
Aspyra Enhances CyberLAB LIS with Added Data Sharing Capabilities
-
Business Wire
Mon, Oct 12, 2009
Aspyra to Demonstrate Teleradiology and Interoperabilty with AccessRAD RIS/PACS at RSNA 2009
-
Business Wire
Wed, Sep 30, 2009
Aspyra Receives Notice from NYSE Amex LLC
-
Business Wire
More Press Releases
Fri, Nov 13, 2009
Cashing In on Obamacare
If you stop grousing for a few minutes, you might find a way to make some money.
-
Fool.com Headlines
Thu, Aug 27, 2009
Aspyra's EBITDA Hits Three Year Low
-
StockTrendNews.com e...
Wed, Aug 26, 2009
T12-NEWS reports that the Aspyra's Revenue for its 12 month ended June 30, 2009 Decreased by -18.03%
-
StockTrendNews.com s...
Tue, Aug 25, 2009
OPS Ranking of "8" Reiteration for Aspyra
-
StockTrendNews.com o...
Aspyra's Free Cash Flow Improves 54%
-
StockTrendNews.com f...
More News
Wed, Mar 04, 2009
No Risk Stock Market Investing
During the recent market volatility many investors have seen their retirement savings vanish into thin air. With stock markets trading at levels not seen in many years, lots of future would-be retirees are wondering if they could ever stop working. As a result many mutual fund holders are converting the stock portion of their portfolios into fixed income. The selling has left few believers in the stock market’s potential for <a
[More...]
-
home: iStockAnalyst....
More Blogs